ciprofloxacin has been researched along with endothelin-1 in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Arner, A; Boels, PJ; Oldner, A; Persson, B; Rossi, P; Weitzberg, E | 1 |
| Boitiaux, JF; Cazes, A; Delclaux, C; Devillier, P; Douvry, B; Henno, P; Israël-Biet, D; Lévy, M | 1 |
| Cheng, X; Guan, M; Jolkkonen, J; Lin, X; Liu, C; Liu, F; Liu, Z; Wang, Y; Xiao, T; Zhao, C; Zhao, Y; Zhong, S | 1 |
3 other study(ies) available for ciprofloxacin and endothelin-1
| Article | Year |
|---|---|
Endotoxemic pulmonary hypertension is largely mediated by endothelin-induced venous constriction.
Topics: Animals; Ciprofloxacin; Endothelin-1; Female; Hypertension, Pulmonary; Lipopolysaccharides; Lung; Male; Pyridines; Respiratory Distress Syndrome; Sepsis; Swine; Tetrazoles; Vascular Resistance; Vasoconstriction; Vasodilator Agents | 2008 |
Tobacco-associated pulmonary vascular dysfunction in smokers: role of the ET-1 pathway.
Topics: Acetylcholine; Adult; Aged; Antihypertensive Agents; Blotting, Western; Ciprofloxacin; Endothelin A Receptor Antagonists; Endothelin B Receptor Antagonists; Endothelin-1; Endothelium, Vascular; Enzyme-Linked Immunosorbent Assay; Female; Humans; Male; Middle Aged; Oligopeptides; Peptides, Cyclic; Piperidines; Pulmonary Circulation; Receptor, Endothelin A; Receptor, Endothelin B; Smoking; Vascular Diseases; Vasodilation; Vasodilator Agents | 2011 |
Long-term modification of gut microbiota by broad-spectrum antibiotics improves stroke outcome in rats.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Ciprofloxacin; Cytokines; Endothelin-1; Fatty Acids, Volatile; Gastrointestinal Microbiome; Infarction; Meropenem; Metronidazole; Rats; Stroke; Vancomycin | 2022 |